Lamotrigine versus carbamazepine monotherapy for epilepsy

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Gamble, Carrol L ^a   Williamson, Paula R ^a   Marson, Anthony G ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Departments of Neurology   (United Kingdom)

Author keywords

Adult; Anticonvulsants *therapeutic use ; Carbamazepine *therapeutic use ; Child; Epilepsies, partial drug therapy ; Epilepsy *drug therapy ; Epilepsy, generalized drug therapy ; Humans; Randomized controlled trials as topic; Triazines *therapeutic use

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE;

CLINICAL TRIAL; COCHRANE LIBRARY; DRUG WITHDRAWAL; EPILEPSY; FOCAL EPILEPSY; GRAND MAL SEIZURE; HUMAN; MONOTHERAPY; REVIEW; TONIC CLONIC SEIZURE; UNSPECIFIED SIDE EFFECT;

EID: 77950101485     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001031.pub2     Document Type: Review

References (49)

1. Brodie 1995 A {published and unpublished data} * Brodie MJ, Richens A, Yuen AWC, for UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345(8948):476-9.
2. Gillham R. Use of SEALS, a quality of life instrument, in evaluating lamotrigine and carbamazepine monotherapy. Epilepsia 1995;36 (Suppl 3):S186-7.
3. Gillham R, Kane K, Bryant-Comstock L, Brodie MJ. A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure. Seizure 2000;9(6):375-9.
4. Brodie 1995 B {published and unpublished data} * Brodie MJ, Richens A, Yuen AWC, for UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345(8948):476-9.
5. Gillham R. Use of SEALS, a quality of life instrument, in evaluating lamotrigine and carbamazepine monotherapy. Epilepsia 1995;36 (Suppl 3):S186-7.
6. Gillham R, Kane K, Bryant-Comstock L, Brodie MJ. A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure. Seizure 2000;9(6):375-9.
7. Brodie 1999 {published and unpublished data} Brodie MJ, Giorgi L, and the Lamotrigine Elderly Study Group. A multicenter double-blind randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsia 1998;39 (Suppl 6):72.
8. * Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Research 1999; Vol. 37, issue 1:81-7.
9. Brodie MJ, Read CL, Gillham RA, Sweet RM, Kane K. Lack of neuropsychological effects of lamotrigine compared to carbamazepine as monotherapy. Epilepsia 1999;40 (Suppl 2):94.
10. Nieto-Barrera 2001 {published and unpublished data} * Nieto-Barrera M, Brozmanova M, Capovilla G, Christie W, Pedersen B, Kane K, et al.A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. Epilepsy Research 2001; Vol. 46, issue 2:145-55.
11. Reunanen 1996 {published and unpublished data} * Reunanen M, Dam M, Yuen AW. A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. Epilepsy Research 1996; Vol. 23, issue 2:149-55.
12. Severi S, Bianchi A, Zolo P, Muscas GC. Lamotrigine monotherapy in patients with partial epilepsy. Epilepsia 1995;36 (Suppl 3):S113.
13. Severi S, Cantelmi T, Bianchi A, Zolo P. Efficacy and safety of lamotrigine in patients with partial epilepsy: preliminary data. Bollettino Lega Italiana Contro L'Epilessia 1993;82-83:139-43.
14. Severi S, Muscas GC, Bianchi A, Zolo P. Efficacy and safety of lamotrigine monotherapy in partial epilepsy. Bollettino Lega Italiana Contro L'Epilessia 1994;86-87:149-51.
15. Yuen AWC, Chapman A. Interim report on an open multicentre lamotrigine (Lamictal) versus carbamazepine monotherapy trial in patients with epilepsy. Canadian Journal of Neurological Sciences. 1993; Vol. 20 (Suppl 4):S150.
16. Yuen AWC, Chapman A. Interim report on an open multicentre lamotrigine (Lamictal) versus carbamazepine monotherapy trial in patients with epilepsy. Epilepsia 1993;34 (Suppl 2):159.
17. Reunanen LTG = 100 {published and unpublished data} Dummy trial identifier to allow sensitivity analyses to be conducted on how the two LTG arms from Reunanen 1996 are included in the meta-analysis. Excludes LTG 200 mg arm and compares LTG 100 mg arm with CBZ arm.
18. Reunanen LTG = 100CR {published and unpublished data} Dummy trial identifier to allow sensitivity analyses to be conducted on how the two LTG arms from Reunanen 1996 are included in the meta-analysis. Excludes LTG 200 mg arm. Compares the LTG 100 mg arm with 50% of the CBZ arm selected at random.
19. Reunanen LTG = 200 {published and unpublished data} Dummy trial identifier to allow sensitivity analyses to be conducted on how the two LTG arms from Reunanen 1996 are included in the meta-analysis. Excludes LTG 100 mg arm and compares LTG 200 mg arm with CBZ arm.
20. Reunanen LTG = 200CR {published and unpublished data} Dummy trial identifier to allow sensitivity analyses to be conducted on how the two LTG arms from Reunanen 1996 are included in the meta-analysis. Excludes LTG 100 mg arm. Compares the LTG 100 mg arm with 50% of the CBZ arm not selected at random for Reunanen LTG = 100 CR.
21. Carmant 2001 {published data only} * Carmant L, Curtis P, Moorat AM. Switching paediatric patients to monotherapy: efficacy and tolerability for lamotrigine compared with carbamazepine. Epilepsia 2001;42 (Suppl 7):170.
22. Czapinski 1997 {published data only} * Czapinski P, Terczynski A, Czapinska E. Open randomised comparative study of vigabatrin (VGB) and lamotrigine (LTG) efficacy in monotherapy of patients with drug-resistant epilepsy with partial complex seizures resistant to carbamazepine. Epilepsia. 1997; Vol. 38 (Suppl 3):35.
23. Czapinski P, Terczynski A, Czapinska E. Open randomized comparative study of vigabatrin (VGB) and lamotrigine (LTG) efficacy in monotherapy of patients with drug-resistant epilepsy with partial complex seizures resistant to carbamazepine (CBZ). Journal of the Neurological Sciences 1997;150 (Suppl):S96.
24. Czapinski P, Terczynski A, Czapiska E. Open randomized comparative study of vigabatrin (VGB) and lamotrigine (LTG) efficacy in monotherapy of patients with drug-resistant epilepsy with partial complex seziures resistant to carbamazepine (CBZ). Journal of Neurology. 1997; Vol. 244 (Suppl 3):S34.
25. Fakhoury 2000 {published data only} * Fakhoury T, Gazda S, Nanry KP, Hammer AE, Barrett PS. Comparison of monotherapy with lamotrigine versus carbamazepine in patients with uncontrolled epilepsy with a broad spectrum of seizure types. Epilepsia 2000;41 (Suppl 7):107.
26. Gilliam 1998 {published data only} * Gilliam F, Vazquez B, Sackellares JC, Chang GY, Messenheimer J, Nyberg J, et al.An active-control trial of lamotrigine monotherapy for partial seizures. Neurology 1998;51(4):1018-25.
27. Jawad 1989 {published data only} * Jawad S, Richens A, Goodwin G, Yuen WC. Controlled trial of lamotrigine (Lamictal) for refractory partial seizures. Epilepsia 1989;30(3):356-63.
28. Martinez 2000 {published data only} * Martinez W, Kaminow L, Nanry KP, Hammer AE, Barrett PS. Evaluation of lamotrigine versus carbamazepine, phenytoin, or divalproex sodium as monotherapy for epilepsy patients who failed or could not tolerate previous antiepileptic drug therapy. Epilepsia 2000;41 (Suppl 7):100.
29. Nanry KP, Martinez W, Li H, Hammer AE, Barrett PS. Epilepsy patients switched from older antiepileptic drugs to lamotrigine monotherapy show improvement in quality of life. Epilepsia 2000;41 (Suppl 7):176.
30. Motte 1997 {published data only} * Motte J, Trevathan E, Arvidsson JFV, Barrera MN, Mullens EL, Manasco P. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. New England Journal of Medicine 1997;337(25):1807-12.
31. Steiner 1999 {published data only} * Steiner TJ, Dellaportas CI, Findley LJ, Gross M, Gibberd FB, Perkin GD, et al.Lamotrigine monotherapy in newly diagnosed untreated epilepsy; a double-blind comparison with phenytoin. Epilepsia 1999;40(5):601-7.
32. Stolarek 1994 {published data only} * Stolarek I, Blacklaw J, Forrest G, Brodie MJ. Vigabatrin and lamotrigine in refractory epilepsy. Journal of Neurology, Neurosurgery, and Psychiatry 1994;57(8):921-4.
33. Ramsay 2003 {published data only} * Ramsay RE, Rowan AJ, Pryor FM, Collins JF, DVA Coop Study Group 428. Treatment of seizures in the elderly: final analysis from DVA Cooperative Study. Epilepsia. 2003; Vol. 44 (Suppl 9):170.
34. Saetre 2004 {published data only} * Saetre E, Perucca E, Gjerstad L, Ansteensen G, O'Neill F, Winter P. An international multi-centre double-blind randomised comparative trial of lamotrigine and slow release carbamazepine in elderly patients with newly diagnosed epilepsy: a preliminary analysis. Epilepsia. 2004; Vol. 45 (Suppl 3):135.
35. SANAD {published data only} http://www.liv.ac.uk/ neuroscience/sanad.
36. Steinhoff 2004 {published data only} * Steinhoff BJ, Ueberall MA, Siemes H, Bergmann L. The lam-safe study: lamotrigine versus carbabazepine and valproic acid in newly diagnosed focal and generalized epilepsies in adolescents and adults. Epilepsia. 2004; Vol. 45 (Suppl 3):68.
37. Brodie 1995 Brodie MJ, Richens A, Yuen AWC, for UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345(8948):476-9.
38. Chadwick 1994 Chadwick DW. Valproate in the treatment of partial epilepsies. Epilepsia 1994;35 (Suppl 5):96-8.
39. Commission 1998 Commission on antiepileptic drugs. Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy. Epilepsia 1998;39(7):799-803.
40. Higgins 2005 Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. Cochrane Database of Systematic Reviews 2005, Issue 3.
41. Jacoby 1998 Jacoby A, Buck D, Baker G, McNamee P, Graham-Jones S, Chadwick D. Uptake and costs of care for epilepsy: findings from a UK regional study. Epilepsia 1998;39(7):776-86.
42. Marson 1996 Marson AG, Kadir ZA, Chadwick DW. New antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ 1996;313(7066):1169-74.
43. Marson 2000 Marson AG, Williamson PR, Hutton JL, Clough HE, Chadwick DW. Carbamazepine versus valproate monotherapy for epilepsy (Cochrane Review). Cochrane Database of Systematic Reviews 2000, Issue 3.[Art. No.: CD001030. DOI: 10.1002/14651858.CD001030]
44. Ramaratnam 2002 Ramaratnam S, Marson AG, Baker GA. Lamotrigine add-on for drug-resistant partial epilepsy (Cochrane Review). Cochrane Database of Systematic Reviews 2002, Issue 2.[Art. No.: CD001909. DOI: 10.1002/14651858.CD001909]
45. Taylor 2001 Taylor S, Tudur Smith C, Williamson PR, Marson AG. Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizures (Cochrane Review). Cochrane Database of Systematic Reviews 2001, Issue 4.[Art. No.: CD002217. DOI: 10.1002/14651858.CD002217]
46. Tudur Smith 2001 Tudur Smith C, Marson AG, Williamson PR. Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures (Cochrane Review). Cochrane Database of Systematic Reviews 2001, Issue 4.[Art. No.: CD001769. DOI: 10.1002/14651858.CD001769]
47. Tudur Smith 2002 Tudur Smith C, Marson AG, Clough HE, Williamson PR. Carbamazepine versus phenytoin monotherapy for epilepsy (Cochrane Review). Cochrane Database of Systematic Reviews 2002, Issue 2.[Art. No.: CD001911. DOI: 10.1002/14651858.CD001911]
48. Tudur Smith 2003 Tudur Smith C, Marson AG, Williamson PR. Carbamazepine versus phenobarbitone monotherapy for epilepsy (Cochrane Review). Cochrane Database of Systematic Reviews 2003, Issue 1.[Art. No.: CD001904. DOI: 10.1002/14651858.CD001904]
49. Williamson 2000 Williamson PR, Marson AG, Tudur C, Hutton JL, Chadwick DW. Individual patient data meta-analysis of randomized anti-epileptic drug monotherapy trials. Journal of Evaluation in Clinical Practice 2000;6(2):205-14.